Bogic L V, Brace R A, Cheung C Y
Division of Perinatal Medicine, Department of Reproductive Medicine, University of California, San Diego, La Jolla, California 92093-0802, USA.
Placenta. 2001 Apr;22(4):265-75. doi: 10.1053/plac.2001.0627.
The receptor tyrosine kinases, kinase-insert domain-containing receptor (KDR) and fms-like tyrosine kinase (Flt-1), and their ligand vascular endothelial growth factor (VEGF) are essential for the development and maintenance of placental vascular function during pregnancy. To further understand the role of VEGF in mediating angiogenesis and vascular permeability during development, the cellular localization of KDR and Flt-1 mRNA and protein, and the distribution of(125)I-VEGF binding sites in placenta, chorion and amnion of ovine fetuses were examined at three different gestational ages. In placentae at 62, 103 and 142 days, the predominant site of KDR mRNA and protein, and VEGF binding was the maternal vascular endothelium. In addition, a specific, although weak, signal for KDR mRNA was found in the maternal epithelium. At 103 and 142 days but not 62 days gestation, KDR mRNA and protein as well as VEGF binding sites were abundantly present in the endothelium of villous blood vessels. In the fetal membranes at 62, 103 and 142 days gestation, KDR mRNA and protein were expressed in the amniotic epithelium and intramembranous blood vessel endothelium, where binding of(125)I-VEGF was strong. There was no KDR mRNA or VEGF binding in the chorionic cytotrophoblast. Flt-1 expression was not detectable in placentae or fetal membranes at the three ages studied. In summary, the results demonstrated that VEGF receptors are present in the maternal and fetal vasculatures of the ovine placenta. This expression is consistent with a capillary growth-promoting function of KDR and its ligand VEGF. Further, the presence of KDR and VEGF binding sites in ovine fetal membranes suggests a role for VEGF in promoting intramembranous vascularity and permeability throughout gestation.
受体酪氨酸激酶、含激酶插入结构域受体(KDR)和fms样酪氨酸激酶(Flt-1)及其配体血管内皮生长因子(VEGF)对于孕期胎盘血管功能的发育和维持至关重要。为了进一步了解VEGF在发育过程中介导血管生成和血管通透性的作用,在三个不同的妊娠阶段检测了绵羊胎儿胎盘、绒毛膜和羊膜中KDR和Flt-1 mRNA及蛋白的细胞定位,以及(125)I-VEGF结合位点的分布。在妊娠62、103和142天的胎盘中,KDR mRNA和蛋白以及VEGF结合的主要部位是母体血管内皮。此外,在母体上皮中发现了KDR mRNA的特异性信号,尽管较弱。在妊娠103和142天而非62天时,绒毛血管内皮中大量存在KDR mRNA和蛋白以及VEGF结合位点。在妊娠62、103和142天的胎膜中,KDR mRNA和蛋白在羊膜上皮和膜内血管内皮中表达,(125)I-VEGF在该处结合较强。绒毛膜细胞滋养层中未检测到KDR mRNA或VEGF结合。在所研究的三个年龄段的胎盘或胎膜中均未检测到Flt-1表达。总之,结果表明VEGF受体存在于绵羊胎盘的母体和胎儿脉管系统中。这种表达与KDR及其配体VEGF促进毛细血管生长的功能一致。此外,绵羊胎膜中存在KDR和VEGF结合位点表明VEGF在整个妊娠期促进膜内血管生成和通透性方面发挥作用。